Seres Therapeutics Inc (MCRB)

$9.27 +0.41 (4.63%)
Market Cap 84.94M
Revenue (ttm) 790,000.00
Net Income (ttm) 5.70M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 721.52%
Debt to Equity Ratio 0.00
Volume 76,800
Avg Vol 71,362
Day's Range N/A - N/A
Shares Out 9.59M
Stochastic %K 80%
Beta 0.26
Analysts Sell
Price Target $22.00

Company Profile

Seres Therapeutics, Inc., a clinical-stage company, focuses on developing biotherapeutics for serious diseases. The company develops SER-155, an investigational oral live biotherapeutic to decolonize gastrointestinal pathogens, enhance epithelial barrier integrity, and regulate immune response to prevent bacterial bloodstream infections, as well as other pathogen-associated negative clinical outcomes in patients undergoing allogeneic hematopoietic stem cell transplantation. Its other pipeline pr...

Industry: Biotechnology
Sector: Healthcare
Phone: 617 945 9626
Address:
101 Cambridgepark Drive, Cambridge, United States
mongoosereflexes
mongoosereflexes Apr. 3 at 12:28 PM
$MCRB long sighhhhhh
0 · Reply
DeskIntelMomentum
DeskIntelMomentum Apr. 3 at 4:29 AM
$MCRB biotech company.
0 · Reply
IBCandBIOTECH
IBCandBIOTECH Apr. 2 at 7:26 PM
$MCRB why can’t we hold 9.25+ 🙄
1 · Reply
Thewolf76
Thewolf76 Apr. 2 at 6:59 PM
$MCRB
0 · Reply
Thewolf76
Thewolf76 Apr. 2 at 6:59 PM
$MCRB highest number of trades in one day after 1 month
0 · Reply
CyberSlayers
CyberSlayers Apr. 2 at 6:41 PM
$MCRB Investors are closely watching for Phase 2 data for SER-155, which is expected in Q2 2026. Success in this program is seen as a major potential catalyst for the stock
1 · Reply
Thewolf76
Thewolf76 Apr. 2 at 5:56 PM
$MCRB 👀👀👀😊
1 · Reply
Thewolf76
Thewolf76 Apr. 2 at 5:50 PM
$MCRB Buyout? Nestlé or merck ? 😊🚀
0 · Reply
Thewolf76
Thewolf76 Apr. 2 at 5:48 PM
$MCRB
0 · Reply
Thewolf76
Thewolf76 Apr. 2 at 5:47 PM
$MCRB I can't wait to get paid, justice always comes. After a long wait, so much satisfaction is about to arrive, something surprising.
0 · Reply
Latest News on MCRB
Seres Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates

Mar 12, 2026, 7:00 AM EDT - 22 days ago

Seres Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates

Seres Therapeutics, Inc. (MCRB) Discusses Leadership Transition, Strategic Direction and Microbiome Therapeutics Platform Prepared Remarks Transcript

Mar 3, 2026, 11:12 AM EST - 4 weeks ago

Seres Therapeutics, Inc. (MCRB) Discusses Leadership Transition, Strategic Direction and Microbiome Therapeutics Platform Prepared Remarks Transcript

Seres Therapeutics Announces Appointment of Richard N. Kender as Executive Chair and Interim CEO; Provides Business Updates

Mar 2, 2026, 4:05 PM EST - 4 weeks ago

Seres Therapeutics Announces Appointment of Richard N. Kender as Executive Chair and Interim CEO; Provides Business Updates

Seres Therapeutics Pauses Key Drug Study, Cuts Jobs To Save Cash

Feb 12, 2026, 8:29 AM EST - 7 weeks ago

Seres Therapeutics Pauses Key Drug Study, Cuts Jobs To Save Cash

Seres Provides Program and Corporate Updates and Prioritizes Emerging Programs in Inflammatory & Immune Diseases

Feb 12, 2026, 7:00 AM EST - 7 weeks ago

Seres Provides Program and Corporate Updates and Prioritizes Emerging Programs in Inflammatory & Immune Diseases

Seres Therapeutics Announces Publications in Nature Medicine and Journal of Infectious Diseases Highlighting Vowst™ Mechanism of Action and Supporting Broader Live Biotherapeutic Strategy

Jan 6, 2026, 7:00 AM EST - 3 months ago

Seres Therapeutics Announces Publications in Nature Medicine and Journal of Infectious Diseases Highlighting Vowst™ Mechanism of Action and Supporting Broader Live Biotherapeutic Strategy

Seres Therapeutics to Participate in Piper Sandler Healthcare Conference

Nov 24, 2025, 7:00 AM EST - 4 months ago

Seres Therapeutics to Participate in Piper Sandler Healthcare Conference

Seres Therapeutics, Inc. (MCRB) Q3 2025 Earnings Call Transcript

Nov 5, 2025, 2:11 PM EST - 5 months ago

Seres Therapeutics, Inc. (MCRB) Q3 2025 Earnings Call Transcript

Seres Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Updates

Nov 5, 2025, 7:00 AM EST - 5 months ago

Seres Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Updates

Seres Therapeutics to Announce Third Quarter 2025 Financial Results and Business Updates on November 5, 2025

Oct 30, 2025, 7:00 AM EDT - 5 months ago

Seres Therapeutics to Announce Third Quarter 2025 Financial Results and Business Updates on November 5, 2025

Seres Therapeutics Receives Award of Up to $3.6 Million from CARB-X to Develop Liquid Formulation of SER-155

Oct 29, 2025, 7:00 AM EDT - 5 months ago

Seres Therapeutics Receives Award of Up to $3.6 Million from CARB-X to Develop Liquid Formulation of SER-155

Seres Therapeutics to Present New Post Hoc Data From SER-155 Phase 1b Trial at IDWeek 2025, Highlighting Potential to Improve Outcomes in Adults Undergoing Allogeneic Hematopoietic Stem Cell Transplant

Oct 14, 2025, 7:00 AM EDT - 6 months ago

Seres Therapeutics to Present New Post Hoc Data From SER-155 Phase 1b Trial at IDWeek 2025, Highlighting Potential to Improve Outcomes in Adults Undergoing Allogeneic Hematopoietic Stem Cell Transplant

Seres Therapeutics Announces Further Constructive Feedback from FDA on SER-155 Phase 2 Study Protocol and Implements Cost Reduction Actions to Extend Cash Runway

Sep 23, 2025, 7:00 AM EDT - 6 months ago

Seres Therapeutics Announces Further Constructive Feedback from FDA on SER-155 Phase 2 Study Protocol and Implements Cost Reduction Actions to Extend Cash Runway

More companies adopt co-CEO structure

Sep 22, 2025, 12:10 PM EDT - 6 months ago

More companies adopt co-CEO structure

IREN KKR LEN NFLX ORCL SBET

Seres Therapeutics to Participate in H.C. Wainwright 27th Annual Global Investment Conference

Aug 27, 2025, 7:00 AM EDT - 7 months ago

Seres Therapeutics to Participate in H.C. Wainwright 27th Annual Global Investment Conference

Seres Therapeutics, Inc. (MCRB) Q2 2025 Earnings Call Transcript

Aug 6, 2025, 9:47 PM EDT - 8 months ago

Seres Therapeutics, Inc. (MCRB) Q2 2025 Earnings Call Transcript

Seres Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Updates

Aug 6, 2025, 7:00 AM EDT - 8 months ago

Seres Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Updates

SANA

Seres Therapeutics: Speculative Gem Backed By SER‑155 FDA Breakthrough

Jul 29, 2025, 2:09 PM EDT - 8 months ago

Seres Therapeutics: Speculative Gem Backed By SER‑155 FDA Breakthrough

Seres Therapeutics to Announce Second Quarter 2025 Financial Results and Business Updates on August 6, 2025

Jul 22, 2025, 7:01 AM EDT - 9 months ago

Seres Therapeutics to Announce Second Quarter 2025 Financial Results and Business Updates on August 6, 2025

Seres Therapeutics Announces Leadership Transition

Jul 22, 2025, 7:00 AM EDT - 9 months ago

Seres Therapeutics Announces Leadership Transition

Seres Therapeutics Presents Expanded SER-155 Exploratory Biomarker Data at 2025 ASCO Annual Meeting

May 27, 2025, 7:00 AM EDT - 11 months ago

Seres Therapeutics Presents Expanded SER-155 Exploratory Biomarker Data at 2025 ASCO Annual Meeting

Seres Therapeutics, Inc. (MCRB) Q1 2025 Earnings Call Transcript

May 7, 2025, 2:18 PM EDT - 11 months ago

Seres Therapeutics, Inc. (MCRB) Q1 2025 Earnings Call Transcript

Seres Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Updates

May 7, 2025, 7:00 AM EDT - 11 months ago

Seres Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Updates

Seres Therapeutics Presents Data at the 2025 Digestive Disease Week Conference Highlighting the Potential for Live Biotherapeutics to Treat Inflammatory and Immune Diseases

Apr 29, 2025, 7:00 AM EDT - 1 year ago

Seres Therapeutics Presents Data at the 2025 Digestive Disease Week Conference Highlighting the Potential for Live Biotherapeutics to Treat Inflammatory and Immune Diseases

Seres Therapeutics to Announce First Quarter 2025 Financial Results and Business Updates on May 7, 2025

Apr 23, 2025, 7:00 AM EDT - 1 year ago

Seres Therapeutics to Announce First Quarter 2025 Financial Results and Business Updates on May 7, 2025

Seres Therapeutics, Inc. (MCRB) Q4 2024 Earnings Call Transcript

Mar 13, 2025, 11:04 AM EDT - 1 year ago

Seres Therapeutics, Inc. (MCRB) Q4 2024 Earnings Call Transcript

Seres Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Updates

Mar 13, 2025, 7:00 AM EDT - 1 year ago

Seres Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Updates

Seres Therapeutics to Announce Fourth Quarter and Full Year 2024 Financial Results and Provide Business Updates on March 13, 2025

Mar 4, 2025, 7:00 AM EST - 1 year ago

Seres Therapeutics to Announce Fourth Quarter and Full Year 2024 Financial Results and Provide Business Updates on March 13, 2025

Seres Therapeutics Receives Feedback From FDA on SER-155 Allogeneic Hematopoietic Stem Cell Transplant (allo-HSCT) Development Approach

Mar 3, 2025, 7:00 AM EST - 1 year ago

Seres Therapeutics Receives Feedback From FDA on SER-155 Allogeneic Hematopoietic Stem Cell Transplant (allo-HSCT) Development Approach

Seres Therapeutics Announces Receipt of Expected $50 Million Installment Payment Related to VOWST Sale

Jan 16, 2025, 7:00 AM EST - 1 year ago

Seres Therapeutics Announces Receipt of Expected $50 Million Installment Payment Related to VOWST Sale

Seres Therapeutics Announces New Translational Biomarker Results from SER-155 Phase 1b Clinical Study and Provides Corporate Updates

Jan 9, 2025, 7:00 AM EST - 1 year ago

Seres Therapeutics Announces New Translational Biomarker Results from SER-155 Phase 1b Clinical Study and Provides Corporate Updates

Seres Therapeutics to Participate in 2025 J.P. Morgan Healthcare Conference

Dec 16, 2024, 7:00 AM EST - 1 year ago

Seres Therapeutics to Participate in 2025 J.P. Morgan Healthcare Conference

Seres Therapeutics, Inc. (MCRB) Q3 2024 Earnings Call Transcript

Nov 13, 2024, 10:28 AM EST - 1 year ago

Seres Therapeutics, Inc. (MCRB) Q3 2024 Earnings Call Transcript

Seres Therapeutics to Announce Third Quarter 2024 Financial Results and Business Updates on November 13, 2024

Nov 6, 2024, 7:00 AM EST - 1 year ago

Seres Therapeutics to Announce Third Quarter 2024 Financial Results and Business Updates on November 13, 2024

Seres Therapeutics Announces Completion of VOWST™ Asset Sale to Société des Produits Nestlé S.A

Sep 30, 2024, 5:15 PM EDT - 1 year ago

Seres Therapeutics Announces Completion of VOWST™ Asset Sale to Société des Produits Nestlé S.A

Seres Therapeutics Stockholders Issue Open Letter to Board of Directors Regarding Reported Engagement With Nestlé

Sep 27, 2024, 3:26 PM EDT - 1 year ago

Seres Therapeutics Stockholders Issue Open Letter to Board of Directors Regarding Reported Engagement With Nestlé

Seres Therapeutics Stockholders Approve Sale of VOWST™ to Nestlé Health Science; Sale Expected to Close on September 30

Sep 26, 2024, 4:01 PM EDT - 1 year ago

Seres Therapeutics Stockholders Approve Sale of VOWST™ to Nestlé Health Science; Sale Expected to Close on September 30

Seres Therapeutics' Strategic Sale Of Vowst Warrants A Rating Upgrade

Sep 23, 2024, 12:14 AM EDT - 1 year ago

Seres Therapeutics' Strategic Sale Of Vowst Warrants A Rating Upgrade

Seres Therapeutics to Participate in Cantor 2024 Global Healthcare Conference

Sep 13, 2024, 7:00 AM EDT - 1 year ago

Seres Therapeutics to Participate in Cantor 2024 Global Healthcare Conference

Seres Therapeutics Reports SER-155 Phase 1b Placebo-Controlled Cohort 2 Study Safety and Clinical Results in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant (allo-HSCT)

Sep 12, 2024, 7:00 AM EDT - 1 year ago

Seres Therapeutics Reports SER-155 Phase 1b Placebo-Controlled Cohort 2 Study Safety and Clinical Results in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant (allo-HSCT)

Seres Therapeutics, Inc. (MCRB) Q2 2024 Earnings Call Transcript

Aug 13, 2024, 3:35 PM EDT - 1 year ago

Seres Therapeutics, Inc. (MCRB) Q2 2024 Earnings Call Transcript

Seres Therapeutics to Announce Second Quarter 2024 Financial Results and Business Update on August 13, 2024

Aug 6, 2024, 7:00 AM EDT - 1 year ago

Seres Therapeutics to Announce Second Quarter 2024 Financial Results and Business Update on August 13, 2024

Seres Therapeutics Announces Signing of VOWST™ Asset Purchase Agreement with Nestlé Health Science

Aug 6, 2024, 7:00 AM EDT - 1 year ago

Seres Therapeutics Announces Signing of VOWST™ Asset Purchase Agreement with Nestlé Health Science

Seres Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Jun 7, 2024, 4:00 PM EDT - 1 year ago

Seres Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Nestlé Health Science agrees to acquire global rights to VOWST®, product it launched in June 2023

Jun 6, 2024, 7:00 AM EDT - 1 year ago

Nestlé Health Science agrees to acquire global rights to VOWST®, product it launched in June 2023

Seres Therapeutics Enters Into Memorandum of Understanding For Vowst™ Asset Sale to Nestlé Health Science

Jun 6, 2024, 6:30 AM EDT - 1 year ago

Seres Therapeutics Enters Into Memorandum of Understanding For Vowst™ Asset Sale to Nestlé Health Science

Seres Therapeutics, Inc. (MCRB) Q1 2024 Earnings Call Transcript

May 11, 2024, 5:34 PM EDT - 2 years ago

Seres Therapeutics, Inc. (MCRB) Q1 2024 Earnings Call Transcript

Seres Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updates

May 8, 2024, 7:00 AM EDT - 2 years ago

Seres Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updates

Seres Therapeutics to Announce First Quarter 2024 Financial Results and Business Update on May 8, 2024

May 6, 2024, 9:30 AM EDT - 2 years ago

Seres Therapeutics to Announce First Quarter 2024 Financial Results and Business Update on May 8, 2024

mongoosereflexes
mongoosereflexes Apr. 3 at 12:28 PM
$MCRB long sighhhhhh
0 · Reply
DeskIntelMomentum
DeskIntelMomentum Apr. 3 at 4:29 AM
$MCRB biotech company.
0 · Reply
IBCandBIOTECH
IBCandBIOTECH Apr. 2 at 7:26 PM
$MCRB why can’t we hold 9.25+ 🙄
1 · Reply
Thewolf76
Thewolf76 Apr. 2 at 6:59 PM
$MCRB
0 · Reply
Thewolf76
Thewolf76 Apr. 2 at 6:59 PM
$MCRB highest number of trades in one day after 1 month
0 · Reply
CyberSlayers
CyberSlayers Apr. 2 at 6:41 PM
$MCRB Investors are closely watching for Phase 2 data for SER-155, which is expected in Q2 2026. Success in this program is seen as a major potential catalyst for the stock
1 · Reply
Thewolf76
Thewolf76 Apr. 2 at 5:56 PM
$MCRB 👀👀👀😊
1 · Reply
Thewolf76
Thewolf76 Apr. 2 at 5:50 PM
$MCRB Buyout? Nestlé or merck ? 😊🚀
0 · Reply
Thewolf76
Thewolf76 Apr. 2 at 5:48 PM
$MCRB
0 · Reply
Thewolf76
Thewolf76 Apr. 2 at 5:47 PM
$MCRB I can't wait to get paid, justice always comes. After a long wait, so much satisfaction is about to arrive, something surprising.
0 · Reply
Autism_Squared
Autism_Squared Apr. 2 at 5:47 PM
$MCRB it is back in trending 😏
0 · Reply
Thewolf76
Thewolf76 Apr. 2 at 5:46 PM
$MCRB 👀👀👀🚀🚀🚀🔥🔥
0 · Reply
Thewolf76
Thewolf76 Apr. 2 at 5:09 PM
$MCRB The time has come to get paid for this long wait. Don't give up now... The best is about to begin.
0 · Reply
Thewolf76
Thewolf76 Apr. 2 at 4:54 PM
$MCRB finally... what were you waiting for to get in touch?
0 · Reply
MikeyDread
MikeyDread Apr. 2 at 4:49 PM
$MCRB play along Wall St games… get paid… it’s coming
0 · Reply
Thewolf76
Thewolf76 Apr. 2 at 3:24 PM
$MCRB
0 · Reply
Thewolf76
Thewolf76 Apr. 2 at 3:23 PM
$MCRB @BioCrazy1 are you alive?
0 · Reply
Tritsortreat2020
Tritsortreat2020 Apr. 2 at 3:00 PM
$MCRB I look forward to whatever happens, happens. then we can all stop looking @LionNoRichy pointless and annoying posts. hes not the only one .
1 · Reply
Thewolf76
Thewolf76 Apr. 2 at 2:31 PM
$MCRB @SenefAS
1 · Reply
Thewolf76
Thewolf76 Apr. 2 at 2:23 PM
$MCRB I understand your frustration, I've been in this for a long time too. But the worst is over, friend, this company will be sold.
1 · Reply
Thewolf76
Thewolf76 Apr. 2 at 2:17 PM
$MCRB 👀🚀
0 · Reply
LionNoRichy
LionNoRichy Apr. 2 at 2:03 PM
$MCRB so dead here
1 · Reply